The DOI matches its Crossref record.
Sustained Release and Standard Methylphenidate Effects on Cognitive and Social Behavior in Children With Attention Deficit Disorder
Abstract
Two studies were conducted to investigate the relative effects of sustained release methylphenidate (Ritalin [SR-20]) and standard methylphenidate (Ritalin, 10 mg, administered twice daily). In the first study, 13 boys with attention deficit disorder participating in a summer treatment program went through a double-blind, within-subject trial of each form of methylphenidate and placebo. Measures of social and cognitive behavior were gathered in classroom and play settings. Although group analyses of the data showed that both drugs were effective and there were few differences between them, standard methylphenidate was superior to SR-20 on several important measures of disruptive behavior. Furthermore, analyses of individual responsivity showed clearly that most boys responded more positively to standard methylphenidate than to SR-20. The second study involved a partially overlapping group of nine boys with attention deficit disorder participating in the same summer treatment program. Also double-blind, within-subject, and placebo controlled, this study tracked the time courses of the two forms of methylphenidate. Both were shown to have similar time courses on the Abbreviated Conners Rating Scale and other measures, but SR-20 had a slower onset than did the standard drug form on a continuous performance task. Effects of SR-20 were still evident eight hours after ingestion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Specifically, the short duration of action of available stimulants necessitates multiple daily doses for many children to provide effective symptom management (Pelham et al., 1987;Swanson et al., 1978).”
From Analog Classroom Assessment of a Once-Daily Mixed Amphetamine Formulation, SLI381 (ADDERALL XR), in Children With ADHD (2003) · cites this paper as Pelham et al., 1987
Citations
Cited by
Sorted by citations
Greenhill, L. L., Pliszka, S., & Dulcan, M. K. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200202001-00003 · Cited by 927
Child maltreatment and the developing HPA axis
Tarullo, A. R., & Gunnar, M. R. (2006) · Hormones and Behavior · doi:10.1016/j.yhbeh.2006.06.010 · Cited by 737
Dulcan, M. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199710001-00007 · Cited by 628
Pharmacokinetics and Clinical Effectiveness of Methylphenidate
Kimko, H. C., Cross, J. T., & Abernethy, D. R. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937060-00002 · Cited by 520
“When the effects of placebo, immediate release formulation (10mg twice daily) or sustained release formulation (20mg daily) were compared in 13 preadolescent males with ADHD in crossover trials, both formulations resulted in better mean ratings on measures of social behaviour than placebo, but the immediate release fo…”
BackgroundMethylphenidate: Its Pharmacology and Uses
Challman, T. D., & Lipsky, J. J. (2000) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)64618-1 · Cited by 568
Pelham, W. E., Gnagy, E. M., Burrows-Maclean, L., Williams, A., Fabiano, G. A., Morrisey, S. M., Chronis, A. M., Forehand, G. L., Nguyen, C. A., Hoffman, M. T., et al. (2001) · Pediatrics · doi:10.1542/peds.107.6.e105 · Cited by 378
Self-citationMethylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Ramstad, E., Krogh, H. B., Nilausen, T. D., Skoog, M., Holmskov, M., Rosendal, S., Groth, C., Magnusson, F. L., Moreira-Maia, C. R., et al. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub2 · Cited by 347
CONNOR, D. F., GLATT, S. J., LOPEZ, I. D., JACKSON, D., & MELLONI, R. H. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200203000-00004 · Cited by 333
Treatment of Attention-Deficit/Hyperactivity Disorder: Overview of the Evidence
Brown, R. T., Amler, R. W., Freeman, W. S., Perrin, J. M., Stein, M. T., Feldman, H. M., Pierce, K., & Wolraich, M. L. (2005) · PEDIATRICS · doi:10.1542/peds.2004-2560 · Cited by 331
Methylphenidate: Its Pharmacology and Uses
Challman, T. D., & Lipsky, J. J. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.7.711 · Cited by 313
Stress Neurobiology and Developmental Psychopathology
Gunnar, M. R., & Vázquez, D. M. (2015) · Wiley eBooks · doi:10.1002/9780470939390.ch13 · Cited by 291
Pelham, W. E., Carlson, C. L., Sams, S. E., Vallano, G., Dixon, M. J., & Hoza, B. (1993) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.61.3.506 · Cited by 266
Self-citationSpencer, T., Biederman, J., Wilens, T., Faraone, S., Prince, J., Gerard, K., Doyle, R., Parekh, A., Kagan, J., & Bearman, S. K. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.8.775 · Cited by 250
“Multiple anxiety disorders ($2) 5 (19) 1 (4) At least 1 anxiety disorder 14 (52) 7 (26) Substance dependence 4 (15) .”
BackgroundSwanson, J., Gupta, S., Lam, A., Shoulson, I., Lerner, M., Modi, N., Lindemulder, E., & Wigal, S. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.2.204 · Cited by 248
Swanson, J. M., Wigal, S. B., Wigal, T., Sonuga-Barke, E., Greenhill, L. L., Biederman, J., Kollins, S., Nguyen, A. S., DeCory, H. H., Hirshe Dirksen, S. J., et al. (2004) · Pediatrics · doi:10.1542/peds.113.3.e206 · Cited by 238
Swanson, J., Gupta, S., Guinta, D., Flynn, D., Agler, D., Lerner, M., Williams, L., Shoulson, I., & Wigal, S. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70038-x · Cited by 216
Pharmacotherapy for Children with Attention-Deficit Hyperactivity Disorder
Pelham, W. E. (1993) · School Psychology Review · doi:10.1080/02796015.1993.12085647 · Cited by 207
Self-citationStimulant Medications and the Treatment of Children with ADHD
Swanson, J. M., McBurnett, K., Christian, D. L., & Wigal, T. L. (1995) · Springer eBooks · doi:10.1007/978-1-4757-9044-3_7 · Cited by 207
Dampening of Adrenocortical Responses during Infancy: Normative Changes and Individual Differences
Gunnar, M. R., Brodersen, L., Krueger, K., & Rigatuso, J. (1996) · Child Development · doi:10.1111/j.1467-8624.1996.tb01770.x · Cited by 222
Pelham, W. E., Aronoff, H. R., Midlam, J. K., Shapiro, C. J., Gnagy, E. M., Chronis, A. M., Onyango, A. N., Forehand, G. L., Nguyen, A. H., & Waxmonsky, J. G. (1999) · PEDIATRICS · doi:10.1542/peds.103.4.e43 · Cited by 198
“5-mg Adderall 87 (10) 71 (16) 84 (19) 80 (21) 93 (15) 62 (38)”
Self-citationRendleman, R. L., & Walkup, J. T. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0435-8.00049-4 · Cited by 197
Carlson, C. L., Pelham, W. E., Milich, R., & Dixon, J. (1992) · Journal of Abnormal Child Psychology · doi:10.1007/bf00916549 · Cited by 188
Self-citationConley, R. R., Gupta, S., & Sathyan, G. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x132613 · Cited by 187
Greenhill, L. L., Findling, R. L., Swanson, J. M., & MPH MR ADHD Study Group (2002) · PEDIATRICS · doi:10.1542/peds.109.3.e39 · Cited by 185
King, S., Griffin, S. C., Hodges, Z., Weatherly, H. L. A., Asseburg, C., Richardson, G. A., Golder, S., Taylor, E., Drummond, M., & Riemsma, R. P. (2006) · Health Technology Assessment · doi:10.3310/hta10230 · Cited by 188
Wilens, T. E., & Biederman, J. (1992) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30265-x · Cited by 173
The Role of Sleep Disturbances in Attention Deficit Disorder Symptoms: A Case Study
Dahl, R. E., Pelham, W. E., & Wierson, M. (1991) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/16.2.229 · Cited by 177
Self-citationSwanson, J. M., & Volkow, N. D. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00433-8 · Cited by 173
Levin, E. D., Conners, C. K., Silva, D., Canu, W. H., & March, J. S. (2001) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.9.1.83 · Cited by 169
Swanson, J. (2003) · CNS Drugs · doi:10.2165/00023210-200317020-00004 · Cited by 162
Wilens, T. E., & Decker, M. W. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.002 · Cited by 164
Transdermal Methylphenidate, Behavioral, and Combined Treatment for Children With ADHD.
Pelham, W. E., Burrows-MacLean, L., Gnagy, E. M., Fabiano, G. A., Coles, E. K., Tresco, K. E., Chacko, A., Wymbs, B. T., Wienke, A. L., Walker, K. S., et al. (2005) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.13.2.111 · Cited by 150
“…daily manipulations of dose and the dependent measures described below, has been used in many previous studies on stimulant effects in this setting, and the dependent measures have been shown to be reliable and sensitive to treatment effects (e.g., Pelham et al., 1987, 1989, 1990, 1993, 2002).”
MethodSelf-citationPelham, W. E., Gnagy, E. M., Chronis, A. M., Burrows-MacLean, L., Fabiano, G. A., Onyango, A. N., Meichenbaum, D. L., Williams, A., Aronoff, H. R., & Steiner, R. L. (1999) · PEDIATRICS · doi:10.1542/peds.104.6.1300 · Cited by 138
Self-citationPrasad, V., Brogan, E., Mulvaney, C. A., Grainge, M. J., Stanton, W., & Sayal, K. S. (2012) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-012-0346-x · Cited by 149
Patrick, K. S., & Markowitz, J. S. (1997) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199711/12)12:6 · Cited by 132
Pharmacotherapy of aggression in children and adolescents: efficacy and effect size.
Pappadopulos, E. A., Woolston, S., Chait, A., Perkins, M. B., Connor, D. F., & Jensen, P. S. (2006) · PubMed Central · Cited by 132
MCCRACKEN, J. T., BIEDERMAN, J., GREENHILL, L. L., SWANSON, J. M., MCGOUGH, J. J., SPENCER, T. J., POSNER, K., WIGAL, S., PATAKI, C., ZHANG, Y., et al. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000046863.56865.fe · Cited by 116
Firestone, P., MUSTEN, L. M., Pisterman, S., Mercer, J. A., & Bennett, S. (1998) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.1998.8.13 · Cited by 101
Modi, N. B., Lindemulder, B., & Gupta, S. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/00912700022009080 · Cited by 101
Does methylphenidate improve academic performance? A systematic review and meta-analysis
Kortekaas-Rijlaarsdam, A. F., Luman, M., Sonuga-Barke, E., & Oosterlaan, J. (2019) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-018-1106-3 · Cited by 99
Sustained Release Methylphenidate: Pharmacokinetic Studies in ADDH Males
Birmaher, B. B., Greenhill, L. L., Cooper, T. B., FRIED, J., & MAMINSKI, B. (1989) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198909000-00020 · Cited by 94
Prince, J. B., Wilens, T. E., Biederman, J., Spencer, T. J., Millstein, R., Polisner, D. A., & Bostic, J. Q. (2000) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/10445460050167304 · Cited by 95
“…et al. 1989a; Quinn and Rapoport 1975; Rapoport 1986) and stimulant medications (Wilens and Bie-derman 1992; Swanson et al. 1995; Greenhill 1991; Pelham et al. 1987), NT treatment resulted in significant reductions in broad clinical categories of inattention, impulsivity, and hyperactivity…”
Comparative Effects of Methylphenidate on ADD Girls and ADD Boys
Pelham, W. E., Walker, J. L., Sturges, J. W., & Hoza, J. (1989) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198909000-00021 · Cited by 94
Self-citationRapport, M. D., & Kelly, K. L. (1991) · Clinical Psychology Review · doi:10.1016/0272-7358(91)90138-k · Cited by 93
Santosh, P. J., & Taylor, E. (2000) · European Child & Adolescent Psychiatry · doi:10.1007/s007870070017 · Cited by 94
Social Impact of Stimulant Treatment for Hyperactive Children
Whalen, C. K., & Henker, B. A. (1991) · Journal of Learning Disabilities · doi:10.1177/002221949102400407 · Cited by 88
DUPAUL, G. J., & RAPPORT, M. D. (1993) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199301000-00027 · Cited by 87
Attention-Deficit Hyperactivity Disorder: The Stimulants
Greenhill, L. L. (1995) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(18)30455-3 · Cited by 86
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Storm, M. R. O., Ribeiro, J. P., Skoog, M., Groth, C., Edemann-Callesen, H., Schaug, J. P., Rasmussen, P. D., Huus, C.-M. L., Zwi, M., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub3 · Cited by 118
Fitzpatrick, P. A., Klorman, R., Brumaghim, J. T., & Borgstedt, A. D. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199203000-00008 · Cited by 82
PELHAM, W. E., SWANSON, J. M., FURMAN, M. B., & SCHWINDT, H. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199511000-00018 · Cited by 81
Self-citationThe Laboratory School Protocol
Wigal, S. B., & Wigal, T. L. (2006) · Journal of Attention Disorders · doi:10.1177/1087054705286049 · Cited by 79
“Of particular note, Pelham et al. (i.e., Pelham et al., 1987; Pelham et al., 1990; Pelham et al., 1999; Pelham et al., 2005) have conducted a great number of studies on medications to treat ADHD in the summer treatment program setting but have published only one study for which the measures were…”
BackgroundBuhrmester, D., Whalen, C., Henker, B., MacDonald, V., & Hinshaw, S. (1992) · Journal of Abnormal Child Psychology · doi:10.1007/bf00927119 · Cited by 77
Stevenson, R. D., & Wolraich, M. L. (1989) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(16)36764-5 · Cited by 76
Garland, E. J. (1998) · Journal of Psychopharmacology · doi:10.1177/026988119801200410 · Cited by 77
“…Spansules 1-~ with durations of about 8 h are effective options (Pelham et al., 1990), less predictable effectiveness on some measures of disruptive behavior have been observed with Ritalin SR (Pelham et al., 1987), and after school dosing is still often needed for homework and evening effects.”
BackgroundA Dose-Ranging Study of a Methylphenidate Transdermal System in Children With ADHD
Pelham, W. E., Manos, M. J., Ezzell, C. E., Tresco, K. E., Gnagy, E. M., Hoffman, M. T., Onyango, A. N., Fabiano, G. A., Lopez-Williams, A., Wymbs, B. T., et al. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000157548.48960.95 · Cited by 73
Self-citationNew Formulations of Stimulants for Attention-Deficit Hyperactivity Disorder
Connor, D. F., & Steingard, R. J. (2004) · CNS Drugs · doi:10.2165/00023210-200418140-00005 · Cited by 71
Smith, B. H., Pelham, W. E., Evans, S. W., Gnagy, E. M., Molina, B. S. G., Bukstein, O. G., Greiner, A. R., Myak, C., Presnell, M., & Willoughby, M. T. (1998) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.6.2.187 · Cited by 70
Self-citationTreatment of Attention Deficit Hyperactivity Disorder in Children and Adolescents
Wolraich, M. L., McGuinn, L. J., & Doffing, M. (2007) · Drug Safety · doi:10.2165/00002018-200730010-00003 · Cited by 67
Psychostimulant Rebound in Attention Deficit Disordered Boys
Johnston, C., Pelham, W. E., Hoza, J., & Sturges, J. W. (1988) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198811000-00026 · Cited by 68
Self-citationSinzig, J., Döpfner, M., Lehmkuhl, G., & German Methylphenidate Study Group (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.0011 · Cited by 62
Baweja, R., Mattison, R. E., & Waxmonsky, J. G. (2015) · Pediatric Drugs · doi:10.1007/s40272-015-0144-2 · Cited by 61
Crockett, E. E., Holmes, B., Granger, D. A., & Lyons‐Ruth, K. (2013) · Infancy · doi:10.1111/infa.12015 · Cited by 63
New methylphenidate formulations for the treatment of attention-deficit/hyperactivity disorder
Patrick, K. S., Ángel-González, M., Straughn, A. B., & Markowitz, J. S. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.1.121 · Cited by 61
“Both have been reported to produce comparable beneficial effects in the treatment of ADHD [159-161], although a few specific behavioural differences have been noted [159].”
BackgroundResultPediatric Psychopharmacotherapy: A Review of Recent Research
Gadow, K. D. (1992) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1992.tb00861.x · Cited by 57
Findling, R. L., Quinn, D., HATCH, S. J., Cameron, S. J., DeCory, H. H., & McDowell, M. (2006) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-006-0565-0 · Cited by 56
“While the efficacy of these 1st generation formulations is sustained for longer times compared to the conventional IR formulations [19, 20], the onset of action is perceived to be too slow, and overall they may appear to be less effective than IR formulations given twice daily [21].”
Carlson, C. L., & Bunner, M. R. (1993) · School Psychology Review · doi:10.1080/02796015.1993.12085646 · Cited by 55
Bioavailability of melatonin in humans after day-time administration of D7 melatonin
Fourtillan, J. B., Brisson, A. M., Gobin, P., Ingrand, I., Decourt, J., & Girault, J. (2000) · Biopharmaceutics & Drug Disposition · doi:10.1002/1099-081x(200001)21:1 · Cited by 119
Shader, R. I., Harmatz, J. S., Oesterheld, J. R., Parmelee, D. X., Sallee, F. R., & Greenblatt, D. J. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/00912709922008425 · Cited by 52
Carlson, C. L., Pelham, W. E., Swanson, J. M., & Wagner, J. L. (1991) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1991.tb00324.x · Cited by 52
Self-citationBalthazor, M., Wagner, R. K., & Pelham, W. E. (1991) · Research on Child and Adolescent Psychopathology · doi:10.1007/bf00910563 · Cited by 52
Self-citationD�pfner, M., Gerber, W. D., Banaschewski, T., Breuer, D., Freisleder, F. J., M�ller, G. G.-V., G�nter, M., H�ssler, F., Ose, C., Rothenberger, A., et al. (2004) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-004-1009-3 · Cited by 51
“Individual responsiveness to the preparation may be highly variable, however [2, 23, 24].”
BackgroundModi, N. B., Wang, B., Noveck, R. J., & Gupta, S. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/009127000004001008 · Cited by 50
“Although a sustained-release (SR) formulation is available, reports indicate that the SR preparation exhibits a time lag before it exhibits activity, and the SR preparation may not be as effective as the IR formulation given twice a day.(4,5) OROS (methylphenidate HCl) (ConcertaTM) is a new oral, osmotic, controlled-r…”
BackgroundSonuga-Barke, E. J. S., Swanson, J. M., Coghill, D., DeCory, H. H., & HATCH, S. J. (2004) · BMC Psychiatry · doi:10.1186/1471-244x-4-28 · Cited by 48
Rapport, M. D., Quinn, S. O., DuPaul, G. J., Quinn, E. P., & Kelly, K. L. (1989) · Research on Child and Adolescent Psychopathology · doi:10.1007/bf00917730 · Cited by 47
Drug Treatment for Hyperactive Children
Elia, J. (1993) · Drugs · doi:10.2165/00003495-199346050-00006 · Cited by 44
Auiler, J. F., Liu, K., Lynch, J. M., & Gelotte, C. K. (2002) · Current Medical Research and Opinion · doi:10.1185/030079902125000840 · Cited by 45
“The most frequently reported AEs were headache (6), nausea (4) and decreased appetite (3).”
BackgroundSchachar, R., Ickowicz, A., Crosbie, J., Donnelly, G. A. E., Reiz, J. L., Miceli, P. C., Harsanyi, Z., & Darke, A. C. (2008) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.0039 · Cited by 43
“Although this study was relatively small in size, previous studies have shown that treat-ment effects of MPH can be demonstrated with relatively few patients (Pelham et al. 1987; Pel-ham et al. 1990).”
López, F. A., & Leroux, J. R. (2013) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-013-0106-x · Cited by 43
Ermer, J. C., Adeyi, B. A., & Pucci, M. L. (2010) · CNS Drugs · doi:10.2165/11539410-000000000-00000 · Cited by 42
“The effects of Ritalin SR appeared to diminish 4 hours after administration and were inferior to those of immediate-release methylphenidate at most timepoints, suggesting that it may not be adequate for once-daily dosing.([34]) In healthy adults (n = 35) receiving single doses of Ritalin SR , the pharmacokinetic param…”
MethodEvolution of stimulants to treat ADHD: transdermal methylphenidate
Patrick, K. S., Straughn, A. B., Perkins, J. S., & Ángel-González, M. (2008) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.992 · Cited by 42
Therapeutic Effects of Medication on ADHD: Implications for School Psychologists
DuPaul, G. J., Barkley, R. A., & McMurray, M. B. (1991) · School Psychology Review · doi:10.1080/02796015.1991.12085546 · Cited by 41
Punja, S., Zorzela, L., Hartling, L., Urichuk, L., & Vohra, S. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-002312 · Cited by 40
Pentikis, H. S., SIMMONS, R. D., BENEDICT, M. F., & HATCH, S. J. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200204000-00017 · Cited by 40
Pelham, W. E., Vodde‐Hamilton, M., Murphy, D. A., Greenstein, J. J., & Vallano, G. (1991) · Journal of Clinical Child Psychology · doi:10.1207/s15374424jccp2003_8 · Cited by 40
Self-citationvan Riet‐Nales, D. A., Schobben, A. F. A. M., Egberts, T. C. G., & Rademaker, C. M. A. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.05.005 · Cited by 39
Treatment of ADDH in Mentally Retarded Children: A Preliminary Study
Payton, J. B., Burkhart, J. E., Hersen, M., et al. (1989) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198909000-00019 · Cited by 39
Sunohara, G., Voros, J. G., MALONE, M. A., & Taylor, M. J. (1997) · International Journal of Psychophysiology · doi:10.1016/s0167-8760(97)00746-0 · Cited by 37
Greenhill, L. L., Pliszka, S. R., Dulcan, M. K., Bernet, W., Arnold, V. K., Beitchman, J. H., Benson, R. S., Bukstein, O., Kinlan, J., McClellan, J., et al. (2004) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.2.4.642 · Cited by 36
Pharmacokinetics in Children and Adolescents
Clein, P. D., & Riddle, M. A. (1995) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(18)30452-8 · Cited by 33
Attention‐Deficit/Hyperactivity Disorder
(2006) · Wiley eBooks · doi:10.1002/9780470041000.cedt060 · Cited by 32
Macphee, F. L., Merrill, B. M., Altszuler, A. R., Ramos, M. C., Gnagy, E. M., Greiner, A. R., Coxe, S. J., Raiker, J. S., Coles, E. K., Burger, L., et al. (2019) · School Psychology Review · doi:10.17105/spr-2017-0151.v48-3 · Cited by 31
“…as the acute effects of psychostimulants on such measures (in the very setting we used) have been documented for decades and demonstrated repeatedly (Carlson et al., 1992; Fabiano et al., 2007; Pelham, Aronoff, et al., 1999; Pelham, Gnagy, et al., 1999; Pelham et al., 1985, 1987, 2001, 2005).”
Self-citationAttention deficit hyperactivity disorder--a review.
Williams, C. L., Wright, B., & Partridge, I. (1999) · PubMed Central · Cited by 32
The Predominantly Inattentive Subtype of Attention-Deficit/Hyperactivity Disorder
Solanto, M. V. (2000) · CNS Spectrums · doi:10.1017/s1092852900007069 · Cited by 29
Patin, A., & Hurlemann, R. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-16522-6_10 · Cited by 37
Child and Adolescent Psychopharmacology Update
McVoy, M. K., & Findling, R. L. (2009) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2008.11.002 · Cited by 26
Childress, A. C., Mehrotra, S., Gobburu, J. V. S., McLean, A. M., DeSousa, N. J., & Incledon, B. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2017.0044 · Cited by 28
“In light of these challenges, sustained-release (SR) formulations of MPH were initially developed, but they were not as effective as IR formulations and not widely accepted in clinical practice (Pelham et al. 1987; Swanson et al. 1999, 2003).”
BackgroundClausen, S., Read, S. C., & Tulloch, S. (2005) · CNS Spectrums · doi:10.1017/s109285290000239x · Cited by 26
THE USE OF PSYCHOSTIMULANTS IN THE PEDIATRIC PATIENT
Pliszka, S. R. (1998) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70063-8 · Cited by 27
Endrényi, L., & Tóthfalusi, L. (2010) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j32g6p · Cited by 27
Metadata
- Authors
- Pelham, W. E., Sturges, J., Hoza, J., Schmidt, C., Bijlsma, J. J., Milich, R., & Moorer, S.
- Affiliations
- Florida State University (US)
- Venue
- PEDIATRICS
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 1987-10-01
- Volume
- 80
- Issue
- 4
- Pages
- 491-501
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2158421224
- Cited by
- 167
- References
- 0
- Citations by year
- 2025: 2 · 2023: 2 · 2019: 1 · 2018: 1 · 2017: 4 · 2016: 2 · 2015: 5 · 2013: 5 · 2012: 5
- FWCI
- 3.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PEDIATRICS (publishedVersion)
- PubMed (publishedVersion)
- UKnowledge (University of Kentucky) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
- Social Sciences › Psychology › Neuropsychology and Physiological Psychology › Developmental and Educational Neuropsychology
- Keywords
- methylphenidate, attention deficit disorder, children, cognitive behavior, social behavior, disruptive behavior, drug formulation comparison, time course of drug effects, continuous performance test, Conners rating scales, summer treatment program
- MeSH terms
- Attention Deficit Disorder with Hyperactivity, Child, Cognition, Delayed-Action Preparations, Double-Blind Method, Humans, Male, Methylphenidate, Random Allocation, Social Behavior, Task Performance and Analysis, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review